Table 1.
Clinical and histopathological features of patients with melanoma (primary and metastatic)
| RGP (n = 17) | VGP (n = 28) | MM (n = 14) | |
|---|---|---|---|
| Male/age | 5/59 | 18/61 | 8/71 |
| Site | |||
| Trunk | 8 | 14 | 4 |
| Leg | 6 | 4 | 3 |
| Head/neck | 1 | 3 | 4 |
| Arm | 2 | 5 | 3 |
| Acral | 0 | 2 | 0 |
| Histotype | |||
| SSM | 17 | 19 | |
| NM | 0 | 7 | |
| ALM | 0 | 2 | |
| Level | |||
| I | 10 | 0 | |
| II | 7 | 0 | |
| III | 0 | 3 | |
| IV | 0 | 23 | |
| V | 0 | 2 | |
| Thickness (mm) | 0.14 | 3.41 | |
| Mitosis (mm2) | 0.34 | 8.8 | |
| Ulceration (n) | 0 | 16 | |
| TNM Stage | |||
| 0 | 8 | 0 | |
| I | 8 | 10 | |
| II | 1 | 12 | |
| III | 0 | 3 | |
| IV | 0 | 3 | 14 |
| Follow-up (months) | 42.6 | 41 | 33.6 |
| Relapse at follow-up | 0 | 8 | 14 |
| Status | |||
| Aw/oD | 17 | 18 | 0 |
| AwD | 0 | 4 | 2 |
| DfD | 0 | 6 | 12 |
RGP, radial growth phase; VGP, vertical growth phase; MM, melanoma metastases; NM, nodular melanoma; SSM, superficial spreading melanoma ALM, acral lentiginous melanoma; Aw/oD, alive without disease; AwD, alive with disease; DfD, dead for disease.